Icotrokinra Beneficial for Adults, Teens With Plaque Psoriasis

WEDNESDAY, Nov. 12, 2025-- For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with the targeted oral peptide icotrokinra yields a significantly higher incidence of skin clearance...